Cell Processing Technologies Market Report 2026

The cell processing technologies market size has grown rapidly in recent years. It will grow from $4.89 billion in 2025 to $5.56 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to expansion of cell-based research activities, increasing use of cell culture techniques, growth of regenerative medicine research, availability of advanced laboratory equipment, rising academic and clinical research funding.

The cell processing technologies market size is expected to see rapid growth in the next few years. It will grow to $9.24 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to increasing commercialization of cell therapies, growing demand for scalable cell manufacturing, expansion of personalized medicine applications, rising investments in bioprocess automation, increasing regulatory focus on cell processing standards. Major trends in the forecast period include increasing adoption of automated cell processing systems, rising demand for closed-system cell handling technologies, growing integration of digital process monitoring, expansion of single-use consumables, enhanced focus on cell viability and quality control.

The rising adoption of personalized medicine is expected to drive the growth of the cell processing technologies market going forward. Personalized medicine is a medical approach that tailors treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. The demand for personalized medicine is increasing due to advancements in genomic technologies, which allow precise identification of genetic variations and enable tailored treatments for individuals. Cell processing technologies support personalized medicine by enabling accurate manipulation and preparation of patient-specific cells, making them essential for customized therapies. These technologies improve treatment outcomes by ensuring high-quality, viable cells, advancing the development of targeted and effective medical interventions. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, up from 12 approvals in 2022. Therefore, the rising adoption of personalized therapies is driving the growth of the cell processing technologies market.

Major companies operating in the cell processing technologies market are focusing on developing advanced solutions, such as automated cell therapy manufacturing platforms, to enhance scalability, improve process efficiency and cell quality, and reduce production costs. An automated cell therapy manufacturing platform is a fully integrated system that uses robotics, sensors, and software to carry out the entire process of producing cell-based therapies with minimal manual intervention. For instance, in March 2025, Limula SA, a Switzerland-based life sciences company, launched LimONE, a fully automated cell therapy manufacturing platform designed to streamline the production of advanced therapies, including CAR-T and gene-edited stem cells. LimONE integrates a bioreactor and centrifuge into a single, closed device that uses one consumable across all development stages, accelerating the transition from research to clinical trials and commercial production. This platform helps hospitals, biotech firms, and manufacturers make life-saving, personalized cell and gene therapies more accessible to patients.

In June 2025, StemCell Technologies Canada Inc., a Canada-based biotechnology company, acquired Cellular Highways Ltd. for an undisclosed amount. Through this acquisition, StemCell aims to strengthen its cell therapy manufacturing capabilities by incorporating Cellular Highways’ advanced cell sorting technology, including the VACS-powered Highway1 instrument. Cellular Highways Ltd. is a UK-based biotechnology company specializing in cell processing technologies for both research and therapeutic applications.

Major companies operating in the cell processing technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Cryo-Cell International Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Terumo Corporation, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., PHC Holdings Corporation, Bio-Techne Corporation, StemCell Technologies Inc., Shibuya Corporation, Repligen Corporation, Beckman Coulter Inc., ThermoGenesis Holdings Inc., Ori Biotech Ltd., Biospherix Ltd., Miltenyi Biotec B.V. & Co. KG, Sartorius Stedim Biotech, Cytiva.

North America was the largest region in the cell processing technologies market in 2025. The regions covered in the cell processing technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell processing technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the cell processing technologies market by increasing costs of imported bioreactors, centrifuges, cell counters, sensors, and precision laboratory equipment. Pharmaceutical and biotechnology companies in North America and Europe are most affected due to reliance on imported high-end instruments, while asia-pacific faces cost pressures on research infrastructure expansion. These tariffs are increasing capital expenditure for laboratories and slowing equipment upgrades. However, they are also encouraging domestic manufacturing of laboratory instruments, regional supply chain development, and innovation in modular and cost-efficient cell processing solutions.

The cell processing technologies market research report is one of a series of new reports that provides cell processing technologies market statistics, including cell processing technologies industry global market size, regional shares, competitors with a cell processing technologies market share, detailed cell processing technologies market segments, market trends and opportunities, and any further data you may need to thrive in the cell processing technologies industry. This cell processing technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cell processing technologies refer to a set of methods and tools used to isolate, manipulate, expand, and prepare living cells for research, therapeutic, or diagnostic applications. Their primary purpose is to ensure the controlled handling and modification of cells while maintaining their viability, functionality, and safety for downstream use in regenerative medicine, cell therapy, or laboratory studies.

The primary types of products in cell processing technologies are equipment, consumables, and software. Cell processing equipment refers to specialized instruments and devices designed to manipulate, culture, separate, and prepare living cells for research, therapeutic, or clinical applications. These find applications in oncology, cardiovascular disease, bone repair, neurological disorders, skeletal muscle repair, immune diseases, and others, catering to diverse end users such as pharmaceutical and biotechnology companies, academic research institutes, and others.

The cell processing technologies market consists of revenues earned by entities by providing services such as cell isolation, purification, culture, expansion, genetic modification, quality control testing, and cryopreservation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell processing technologies market also includes sales of cell isolation instruments, automated bioreactors, closed-system processing units, cell counting and analysis devices, and cryopreservation equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.